As of mid-September 2026, CDC data show 3,294 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 95% tied to ongoing outbreaks, primarily carryovers from 2025 clusters in Pennsylvania, South Carolina, and Utah. Over 93% of cases involve unvaccinated or unknown-status individuals, reflecting kindergarten MMR coverage that has fallen to 92.5% nationally amid rising exemptions. Measles' high basic reproduction number sustains chains in under-vaccinated communities, with 8% hospitalization rates and active surveillance via wastewater monitoring and weekly CDC updates. Key upcoming factors include continued fall reporting through year-end and potential PAHO review of U.S. elimination status, which could shift if local transmission persists beyond 12 months.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于2026年美国麻疹病例？
2026年美国麻疹病例？
$7,897,691 交易量
$7,897,691 交易量
2026-12-31
↑3.5千
100%
↑4千
96%
↑4.5千
87%
↑4.5k
86%
↑5千
70%
↑7.5k
15%
↑1万
7%
↑1.25万
2%
$7,897,691 交易量
$7,897,691 交易量
2026-12-31
↑3.5千
$15,502 交易量
100%
↑4千
$240,810 交易量
96%
↑4.5千
$2,930 交易量
87%
↑4.5k
$626 交易量
86%
↑5千
$242,023 交易量
70%
↑7.5k
$194,220 交易量
15%
↑1万
$6,524,884 交易量
7%
↑1.25万
$356,740 交易量
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-September 2026, CDC data show 3,294 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 95% tied to ongoing outbreaks, primarily carryovers from 2025 clusters in Pennsylvania, South Carolina, and Utah. Over 93% of cases involve unvaccinated or unknown-status individuals, reflecting kindergarten MMR coverage that has fallen to 92.5% nationally amid rising exemptions. Measles' high basic reproduction number sustains chains in under-vaccinated communities, with 8% hospitalization rates and active surveillance via wastewater monitoring and weekly CDC updates. Key upcoming factors include continued fall reporting through year-end and potential PAHO review of U.S. elimination status, which could shift if local transmission persists beyond 12 months.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
市场开放时间： Jun 30, 2026, 2:17 PM ET
交易量
$7,897,691结束日期
2027-01-01市场开放时间
Jun 30, 2026, 2:17 PM ETThis market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-September 2026, CDC data show 3,294 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 95% tied to ongoing outbreaks, primarily carryovers from 2025 clusters in Pennsylvania, South Carolina, and Utah. Over 93% of cases involve unvaccinated or unknown-status individuals, reflecting kindergarten MMR coverage that has fallen to 92.5% nationally amid rising exemptions. Measles' high basic reproduction number sustains chains in under-vaccinated communities, with 8% hospitalization rates and active surveillance via wastewater monitoring and weekly CDC updates. Key upcoming factors include continued fall reporting through year-end and potential PAHO review of U.S. elimination status, which could shift if local transmission persists beyond 12 months.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
交易量
$7,897,691结束日期
2027-01-01市场开放时间
Jun 30, 2026, 2:17 PM ETAs of mid-September 2026, CDC data show 3,294 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 95% tied to ongoing outbreaks, primarily carryovers from 2025 clusters in Pennsylvania, South Carolina, and Utah. Over 93% of cases involve unvaccinated or unknown-status individuals, reflecting kindergarten MMR coverage that has fallen to 92.5% nationally amid rising exemptions. Measles' high basic reproduction number sustains chains in under-vaccinated communities, with 8% hospitalization rates and active surveillance via wastewater monitoring and weekly CDC updates. Key upcoming factors include continued fall reporting through year-end and potential PAHO review of U.S. elimination status, which could shift if local transmission persists beyond 12 months.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题